February  2004, 4(1): 135-146. doi: 10.3934/dcdsb.2004.4.135

Optimal control applied to immunotherapy


Department of Mathematics, University of Kentucky, Lexington, KY 40504, United States


Department of Mathematics and Statistics, Murray State University, 6C Faculty Hall, Murray, KY 42071, United States, United States

Received  August 2002 Revised  September 2003 Published  November 2003

We investigate a mathematical model for the dynamics between tumor cells, immune-effector cells, and the cytokine interleukin-2 (IL-2). In order to better determine under what circumstances the tumor can be eliminated, we implement optimal control theory. We design the control functional to maximize the effector cells and interleukin-2 concentration and to minimize the tumor cells. Next, we show that an optimal control exists for this problem. After which, we characterize our unique optimal control in terms of the solutions to the optimality system, which is the state system coupled with the adjoint system. Finally, we analyze the optimal control and optimality system using numerical techniques.
Citation: Thalya Burden, Jon Ernstberger, K. Renee Fister. Optimal control applied to immunotherapy. Discrete and Continuous Dynamical Systems - B, 2004, 4 (1) : 135-146. doi: 10.3934/dcdsb.2004.4.135

K. Renee Fister, Jennifer Hughes Donnelly. Immunotherapy: An Optimal Control Theory Approach. Mathematical Biosciences & Engineering, 2005, 2 (3) : 499-510. doi: 10.3934/mbe.2005.2.499


Urszula Ledzewicz, Heinz Schättler. Drug resistance in cancer chemotherapy as an optimal control problem. Discrete and Continuous Dynamical Systems - B, 2006, 6 (1) : 129-150. doi: 10.3934/dcdsb.2006.6.129


Hsiu-Chuan Wei. Mathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancer. Discrete and Continuous Dynamical Systems - B, 2016, 21 (4) : 1279-1295. doi: 10.3934/dcdsb.2016.21.1279


Urszula Ledzewicz, Heinz Schättler, Mostafa Reisi Gahrooi, Siamak Mahmoudian Dehkordi. On the MTD paradigm and optimal control for multi-drug cancer chemotherapy. Mathematical Biosciences & Engineering, 2013, 10 (3) : 803-819. doi: 10.3934/mbe.2013.10.803


Shuo Wang, Heinz Schättler. Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity. Mathematical Biosciences & Engineering, 2016, 13 (6) : 1223-1240. doi: 10.3934/mbe.2016040


K. E. Starkov, Svetlana Bunimovich-Mendrazitsky. Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy. Mathematical Biosciences & Engineering, 2016, 13 (5) : 1059-1075. doi: 10.3934/mbe.2016030


Shuo Wang, Heinz Schättler. Optimal control for cancer chemotherapy under tumor heterogeneity with Michealis-Menten pharmacodynamics. Discrete and Continuous Dynamical Systems - B, 2019, 24 (5) : 2383-2405. doi: 10.3934/dcdsb.2019100


Alexis B. Cook, Daniel R. Ziazadeh, Jianfeng Lu, Trachette L. Jackson. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival. Mathematical Biosciences & Engineering, 2015, 12 (6) : 1219-1235. doi: 10.3934/mbe.2015.12.1219


Nasser Sweilam, Fathalla Rihan, Seham AL-Mekhlafi. A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies. Discrete and Continuous Dynamical Systems - S, 2020, 13 (9) : 2403-2424. doi: 10.3934/dcdss.2020120


Urszula Ledzewicz, Heinz Schättler, Shuo Wang. On the role of tumor heterogeneity for optimal cancer chemotherapy. Networks and Heterogeneous Media, 2019, 14 (1) : 131-147. doi: 10.3934/nhm.2019007


Amina Eladdadi, Noura Yousfi, Abdessamad Tridane. Preface: Special issue on cancer modeling, analysis and control. Discrete and Continuous Dynamical Systems - B, 2013, 18 (4) : i-iii. doi: 10.3934/dcdsb.2013.18.4i


Benedetto Piccoli. Optimal syntheses for state constrained problems with application to optimization of cancer therapies. Mathematical Control and Related Fields, 2012, 2 (4) : 383-398. doi: 10.3934/mcrf.2012.2.383


Urszula Ledzewicz, Heinz Schättler. The Influence of PK/PD on the Structure of Optimal Controls in Cancer Chemotherapy Models. Mathematical Biosciences & Engineering, 2005, 2 (3) : 561-578. doi: 10.3934/mbe.2005.2.561


Wei Feng, Shuhua Hu, Xin Lu. Optimal controls for a 3-compartment model for cancer chemotherapy with quadratic objective. Conference Publications, 2003, 2003 (Special) : 544-553. doi: 10.3934/proc.2003.2003.544


Ben Sheller, Domenico D'Alessandro. Analysis of a cancer dormancy model and control of immuno-therapy. Mathematical Biosciences & Engineering, 2015, 12 (5) : 1037-1053. doi: 10.3934/mbe.2015.12.1037


Denise E. Kirschner, Alexei Tsygvintsev. On the global dynamics of a model for tumor immunotherapy. Mathematical Biosciences & Engineering, 2009, 6 (3) : 573-583. doi: 10.3934/mbe.2009.6.573


Ellina Grigorieva, Evgenii Khailov. Optimal control of pollution stock. Conference Publications, 2011, 2011 (Special) : 578-588. doi: 10.3934/proc.2011.2011.578


Hang-Chin Lai, Jin-Chirng Lee, Shuh-Jye Chern. A variational problem and optimal control. Journal of Industrial and Management Optimization, 2011, 7 (4) : 967-975. doi: 10.3934/jimo.2011.7.967


Luis A. Fernández, Cecilia Pola. Catalog of the optimal controls in cancer chemotherapy for the Gompertz model depending on PK/PD and the integral constraint. Discrete and Continuous Dynamical Systems - B, 2014, 19 (6) : 1563-1588. doi: 10.3934/dcdsb.2014.19.1563


Frédérique Billy, Jean Clairambault. Designing proliferating cell population models with functional targets for control by anti-cancer drugs. Discrete and Continuous Dynamical Systems - B, 2013, 18 (4) : 865-889. doi: 10.3934/dcdsb.2013.18.865

2021 Impact Factor: 1.497


  • PDF downloads (160)
  • HTML views (0)
  • Cited by (2)

Other articles
by authors

[Back to Top]